Hypotron (Midodrine Hydrochloride)

After oral intake, midodrine is converted to its active metabolite desglymidodrine, which selectively stimulates peripheral alpha‑1 adrenergic receptors. This stimulation causes blood vessels to constrict, increasing systemic vascular resistance and raising blood pressure, especially in the upright posture.

The dosage of Hypotron is individualized. A qualified prescriber determines the appropriate amount based on the patient’s clinical condition, response, and tolerance. Patients should follow the prescribing information and not adjust the dose without medical advice.

Safety data for midodrine hydrochloride in pregnancy and lactation are limited, and the product does not have an established pregnancy category. Healthcare providers must weigh potential benefits against possible risks before prescribing to pregnant or nursing women.

To request Hypotron, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

The primary alternative for orthostatic hypotension is fludrocortisone, a mineralocorticoid that expands plasma volume. Midodrine, the active ingredient in Hypotron, raises blood pressure by vasoconstriction rather than fluid retention, offering a different mechanism that may be preferred when volume overload is a concern.

Store Hypotron at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Hypotron is taken orally, usually with a full glass of water. It is commonly prescribed to be taken during the day, with the last dose not later than early evening to reduce the risk of supine hypertension while sleeping.

The most serious adverse events include severe hypertension, especially when lying down, and rare cases of angioedema or myocardial ischemia. Patients should monitor blood pressure regularly and seek immediate medical attention if they experience sudden, severe headache, chest pain, or swelling of the face or throat.

Hypotron is contraindicated in patients with known hypersensitivity to midodrine or its excipients, those with severe organic heart disease, acute renal failure, or uncontrolled hypertension. Caution is also advised for individuals taking other potent vasoconstrictors or monoamine oxidase inhibitors.